What Is Keratoconus? Symptoms, Causes, and Treatment

Keratoconus is a progressive eye condition in which the cornea, normally dome-shaped, thins and bulges outward into a cone-like form. That distortion scatters light before it reaches the retina, producing blurred and warped vision that worsens over time. It typically shows up in the late teens or twenties, making it an unwelcome companion during some of the most formative years of a person’s life. The condition is more common than many people realize, and while it cannot currently be cured, a range of treatments from specialty contact lenses to corneal surgery can preserve useful vision for the vast majority of those affected.

What Happens Inside the Cornea

The cornea’s strength comes from a tightly woven network of collagen fibers in its middle layer, called the stroma. In keratoconus, that network breaks down. The collagen degrades, the tissue thins, and the cornea gradually loses its ability to hold its normal curved shape. As the cornea steepens and protrudes, light passing through it bends unevenly, creating irregular astigmatism that ordinary glasses struggle to correct.¹

Research has identified specific enzymes involved in this collagen breakdown. One line of investigation points to estrogen-driven pathways: corneal cells can produce their own estrogen, and that locally made hormone appears to activate enzymes that chew through collagen fibers. This may partly explain why keratoconus often progresses during puberty and pregnancy, periods when hormonal shifts are dramatic.²

Early and Advanced Symptoms

The earliest sign most people notice is that their glasses prescription keeps changing, especially for astigmatism. Vision may seem slightly smeared or doubled even with correction, and night driving often becomes noticeably harder because streetlights and headlights develop halos or streaks. Many people visit the optometrist multiple times for new glasses before anyone suspects keratoconus.

As the cone becomes more pronounced, symptoms intensify. Light sensitivity increases, and some people develop ghost images: a single object appears as several overlapping copies. In advanced stages, this phenomenon can affect a single eye, which is a distinctive clue that sets keratoconus apart from more typical refractive errors.³ Contact lens discomfort is another common complaint, because standard soft lenses no longer conform well to the irregular corneal surface.

Causes and Risk Factors

No single cause has been pinpointed, and most researchers view keratoconus as the product of genetic susceptibility colliding with environmental triggers. Family studies consistently show that relatives of affected individuals are at higher risk, and identical twins are far more likely to share the condition than fraternal twins, pointing to a strong hereditary component.⁴ Several candidate genes have been identified, though none on its own accounts for more than a small fraction of cases.⁵

Eye rubbing is the environmental factor that gets the most attention, and for good reason. Vigorous, habitual rubbing physically damages the cells in the corneal stroma, and the damage is proportional to the force and duration of the rubbing.⁶ Not everyone who rubs their eyes develops keratoconus, and not every keratoconus patient is a chronic eye rubber, but the link is strong enough that virtually every specialist will tell newly diagnosed patients to stop rubbing immediately.⁷

Allergic conditions deserve a mention because they feed into the rubbing problem. A large population-based study in Israel found that asthma, allergic rhinitis, and atopic dermatitis were all significantly associated with keratoconus, as was male sex and diabetes.⁸ Allergies make eyes itch, itching leads to rubbing, and rubbing stresses an already vulnerable cornea. Managing allergies aggressively may be one of the few modifiable strategies for slowing the disease.

Who Gets Keratoconus and How Common Is It

Keratoconus is most often diagnosed in people between 20 and 29 years old, and that age group also carries the highest prevalence. A global meta-analysis estimated that about 526 per 100,000 people in that age range have the condition. Rates vary enormously by region: Africa and South Asia report much higher prevalence, while East Asia reports much lower numbers.⁹ Whether these regional differences reflect true biological variation, differences in screening and detection practices, or both remains an open question. Improved diagnostic technology has pushed reported prevalence upward in recent decades, suggesting many milder cases went undetected in earlier surveys.

How Keratoconus Is Diagnosed

A standard eye exam can raise suspicion, but confirming keratoconus and catching it early requires imaging of the cornea’s shape. Corneal tomography is widely considered the gold standard. It maps both the front and back surfaces of the cornea in fine detail, revealing subtle bulging that is invisible to the naked eye and even to basic refraction testing.¹⁰¹¹

Optical coherence tomography (OCT) adds another layer. It can map the thickness of the corneal epithelium, the outermost living layer. In early keratoconus, the epithelium remodels itself to compensate for the bulge underneath, creating a characteristic doughnut-shaped thickness pattern that may be the earliest detectable sign of the disease.¹² This matters because catching keratoconus before it progresses significantly opens the door to treatments that can halt it in its tracks.

Artificial intelligence is making early detection more accessible. A Cochrane review of AI-based systems for spotting subclinical keratoconus found about 90% sensitivity and roughly 96% specificity, meaning these tools catch the vast majority of early cases while producing relatively few false alarms.¹³ Newer systems pairing neural networks with explainable reasoning have achieved similar performance in pilot testing.¹⁴ The practical benefit is that AI could flag suspicious scans in busy clinics, prompting referrals that might otherwise be delayed.

Contact Lenses as the First Line of Vision Correction

Glasses work well enough in the mildest cases, but as the cornea becomes more irregular, contact lenses take over as the primary way to see clearly. The lens creates a smooth optical surface over the distorted cornea, essentially replacing the warped front of the eye with a regular one.

Rigid gas-permeable lenses have been the workhorse option for decades, producing sharper vision than glasses by neutralizing the cornea’s irregular curvature.¹⁵ They can be uncomfortable at first, though, and in more advanced cones, achieving a good fit becomes a real challenge. Scleral lenses, which are larger and vault over the cornea entirely while resting on the white of the eye, have become increasingly popular. They offer a stable optical platform and are generally more comfortable because they do not press on the cone.¹⁶ Hybrid lenses, with a rigid center and soft skirt, and piggyback systems where a soft lens sits underneath a rigid one are other options. The point is that keratoconus lens fitting is a specialty unto itself, often requiring multiple visits and adjustments as the condition changes.¹⁷

Corneal Cross-Linking to Stop Progression

Collagen cross-linking (CXL) is the treatment that changed the trajectory of keratoconus management. It is the only widely available intervention that addresses the underlying problem rather than just correcting vision. The procedure uses riboflavin (vitamin B2) drops and controlled ultraviolet-A light to create new chemical bonds between collagen fibers in the stroma, stiffening the cornea and halting or dramatically slowing its thinning.¹⁸

Clinical studies report that cross-linking stops progression in over 90% of cases, and many patients also see modest improvements in corneal shape and visual clarity afterward.¹⁹ Riboflavin plays a dual role: it acts as the photosensitizer that kicks off the cross-linking chemistry and simultaneously absorbs the UV light so it does not penetrate deeply enough to damage the lens or retina inside the eye.

The traditional “epithelium-off” protocol involves removing the thin outer layer of the cornea so the riboflavin can soak in. A newer “epithelium-on” approach leaves that layer intact, which is less painful and heals faster but historically delivered weaker cross-linking. Ongoing research into optimizing riboflavin concentration and UV dosing is narrowing that effectiveness gap.²⁰ For patients with documented progression, cross-linking is now routinely recommended early, often before significant vision loss has occurred.

Intrastromal Ring Segments

When the cone is too advanced for cross-linking alone to restore acceptable vision but not severe enough to require a transplant, small arc-shaped plastic inserts can be placed within the corneal stroma. These intrastromal corneal ring segments (ICRS) physically reshape the cornea from the inside, flattening the steep cone and reducing irregular astigmatism. Studies have found that the flattening effect is maintained for at least five years after implantation.²¹ Ring segments are sometimes combined with cross-linking: the rings reshape the cornea, and cross-linking locks in the new shape.

When a Corneal Transplant Becomes Necessary

A minority of keratoconus patients eventually need a transplant, typically because the cornea has become too thin, too scarred, or too irregular for lenses or other procedures to provide functional vision. Two main approaches exist. Penetrating keratoplasty (PKP) replaces the full thickness of the cornea with donor tissue. Deep anterior lamellar keratoplasty (DALK) replaces only the front layers, leaving the patient’s own innermost layer intact.

A meta-analysis comparing the two found that DALK carried lower rates of graft rejection, cataracts, and high eye pressure after surgery, making it the safer option overall.²² Visual outcomes, however, have historically been slightly better with PKP.²³ Graft survival is high for both, sitting around 90% or above in large registries.²⁴ The choice between them depends on how deep the scarring extends and the surgeon’s assessment of each patient’s cornea.

Acute Corneal Hydrops

One complication that catches people off guard is acute corneal hydrops. In a severely thinned cornea, a tear can develop in the deepest corneal layers, allowing fluid from inside the eye to rush into the stroma. The cornea suddenly swells, turning cloudy, and vision drops sharply. There may be significant pain and light sensitivity.²⁵ Eye rubbing is often the immediate trigger.

The reassuring news is that hydrops usually resolves on its own over two to three months. When it does not, injection of air or gas into the front chamber of the eye can help push the fluid out and speed healing. Interestingly, research suggests that the tear needs to involve not just the deepest membrane but also the adjacent stroma to actually produce a hydrops, which is why not every thin cornea develops one.²⁶

Keratoconus and LASIK

One of the most important practical consequences of keratoconus is its relationship with laser vision correction. LASIK works by removing corneal tissue to reshape its curvature, and that tissue removal weakens the cornea. In someone with an undetected predisposition to keratoconus, LASIK can trigger a rapid, destabilizing bulge called post-surgical ectasia. Abnormal corneal topography remains the single most important risk factor identified during pre-LASIK screening.²⁷ Young age is another overlooked risk factor, because a younger cornea may not yet show the full extent of an underlying ectatic tendency.

This is why thorough corneal imaging before any refractive surgery is non-negotiable. If tomography reveals even subtle signs of keratoconus or unusually thin corneas, LASIK is generally off the table. Patients who are told they are poor LASIK candidates should take that assessment seriously; the alternative is not slightly worse vision but potential progression to a condition that requires specialty lenses or surgery to manage.²⁸

Living With Keratoconus and Its Impact on Daily Life

Because keratoconus strikes in the teens and twenties, its effects ripple through education, early career development, driving ability, and social life. Qualitative research paints a picture that goes well beyond blurry vision: patients describe feeling isolated, misunderstood by friends and family who cannot see anything wrong with their eyes, and anxious about what the next check-up will reveal. Financial strain is a recurring theme, since specialty lenses and procedures are expensive and the condition begins when most people have the least ability to pay.²⁹

Quality-of-life studies consistently find that keratoconus affects wellbeing beyond what visual acuity scores alone would predict. More advanced disease is generally linked to lower quality-of-life scores, though even people with relatively mild keratoconus report anxiety about progression and frustration with the limitations the condition imposes.³⁰

The Financial Side

The economic burden is real and quantifiable. A decision-analysis model estimated the average lifetime cost of treating keratoconus, above and beyond ordinary vision care, at roughly $25,000. The biggest cost driver is not contact lenses or routine visits but rather the probability of needing a corneal transplant and subsequent regrafts.³¹ Updated U.S. estimates put the inflation-adjusted lifetime cost closer to $29,000 per patient, with the total national burden reaching billions of dollars annually.³² An Australian survey of patient-reported expenses reinforced the same message: keratoconus, despite being classified as a non-blinding condition in most cases, carries a significant public-health cost precisely because it affects people for most of their adult lives.³³

Cross-linking may eventually shift this calculus. By halting progression early, it reduces the number of patients who progress to needing transplants, which is where the largest costs accumulate. Whether that upstream savings offsets the upfront cost of widespread screening and early treatment is an active area of health-economics research.

Emerging Directions in Treatment

Beyond refinements to existing procedures, researchers are exploring tissue engineering and regenerative therapies that aim to rebuild damaged corneal tissue at the cellular level. The long-term vision is that one day it may be possible to restore corneal structure rather than merely stabilize what remains.³⁴ These approaches are still in early stages and not yet available in the clinic, but they represent a fundamentally different strategy from everything currently on offer. For patients diagnosed today, the practical reality is that cross-linking combined with specialty lenses can preserve functional vision indefinitely in most cases, a prognosis that would have been far less certain even 15 years ago.